SCHEMBL6174207

SCHEMBL6174207

CC(c1ccnc(NS(=O)(=O)Nc2ccccc2)c1)C1(C(C)c2ccnc(NS(=O)(=O)Nc3ccccc3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
ATP1A1 P05023 1/20 0.34
ATP1B1 P05026 1/20 0.34
ATP1A3 P13637 1/20 0.34
ATP1B2 P14415 1/20 0.34
ATP1A2 P50993 1/20 0.34
ATP1B3 P54709 1/20 0.34
FXYD2 P54710 1/20 0.34
ATP1A4 Q13733 1/20 0.34
EPHX2 P34913 1/20 0.34
PTGS2 P35354 1/20 0.34
ABL1 P00519 1/20 0.34
BCR P11274 1/20 0.34
IDH1 O75874 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
MAPK1 P28482 2/20 0.33
PLK1 P53350 2/20 0.33
LIPE Q05469 1/20 0.33
OPRL1 P41146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170274 0.90 GPR139 (0.35) TSHRKMT2AABL1BCRSMN1; SMN2
SCHEMBL6172683 0.90 MAPK1 (0.38) TSHRKMT2AATP1A1ATP1B1ATP1A3
SCHEMBL6173261 0.89 IGF1R (0.41) TSHRKMT2AATP1A1ATP1B1ATP1A3
SCHEMBL6172534 0.88 IGF1R (0.40) TSHRKMT2APTGS2ABL1BCR
SCHEMBL6173443 0.88 IGF1R (0.38) TSHRKMT2APTGS2SMN1; SMN2TP53
SCHEMBL6173825 0.85 MAPK1 (0.42) KMT2AEPHX2PTGS2IDH1MAPK1
SCHEMBL6171179 0.84 POLB (0.37) TSHRKMT2AATP1A1ATP1B1ATP1A3
SCHEMBL6172626 0.84 IGF1R (0.40) TSHRKMT2AATP1A1ATP1B1ATP1A3
SCHEMBL6172274 0.83 CYP3A4 (0.40) ABL1MAPK1ALDH1A1PDE2A
SCHEMBL6176861 0.82 PDE2A (0.39) TSHRKMT2AATP1A1ATP1B1ATP1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed